Emrit v. USPTO: Pro Se Litigant’s Patent Suit Dismissed With Prejudice for Jurisdictional Flaws

Case Overview

The Parties

The Patent(s) and Products at Issue

The case record does not publicly disclose specific patent numbers or accused products within the input data available. The action was classified as a patent infringement action, though the precise claims alleged against the USPTO were not detailed in the final disposition order. This absence of identifiable patents or products is itself legally significant — courts reviewing IFP complaints under §1915(e)(2)(B) scrutinize whether a complaint states a cognizable legal claim, and a failure to identify specific patents or infringed products is a fundamental pleading deficiency.

The Verdict & Legal Analysis

Outcome

Chief Judge Baxter issued a dual order on October 23, 2025: 1) **Granted** Emrit’s motion to proceed in forma pauperis (IFP), waiving filing fees based on financial hardship. 2) **Dismissed** the complaint **with prejudice and without leave to amend** pursuant to 28 U.S.C. §1915(e)(2)(B). No damages were awarded. No injunctive relief was addressed. The case was immediately closed upon dismissal.

Verdict Cause Analysis

The dismissal with prejudice under **§1915(e)(2)(B)** is a substantive legal determination, not merely an administrative closing. Under this statute, a court *must* dismiss an IFP complaint if it:

• • **(B)(i)** is frivolous or malicious;
• • **(B)(ii)** fails to state a claim upon which relief may be granted; or
• • **(B)(iii)** seeks monetary relief against a defendant who is immune from such relief.

The precise subsection invoked is referenced in the accompanying Memorandum Opinion, which is not reproduced in the available case data. However, any or all three grounds would apply with considerable force in a patent infringement action against the USPTO:

Sovereign Immunity: The USPTO, as a federal agency, is protected by sovereign immunity under the Eleventh Amendment and the Federal Tort Claims Act framework. Plaintiffs cannot sue federal agencies for patent infringement under **35 U.S.C. §271** in district court without a specific statutory waiver. The Federal Circuit has consistently held that patent infringement claims against federal agencies must be brought under **28 U.S.C. §1498** in the **U.S. Court of Federal Claims**, not in a district court.

Failure to State a Claim: A patent infringement complaint must identify the asserted patent, the accused product or process, and the basis for infringement. Without specific patent numbers or accused activities, a complaint cannot survive §1915 screening.

Frivolousness: Given Emrit’s documented history of multi-district pro se filings, courts have broad discretion to find complaints frivolous when they repeat legally untenable theories.